Vimarsana
Biggest News Aggregation in the World

Page 2 - Ackermans News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ackermans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ackermans Today - Breaking & Trending Today

Hemingways tenants nervous as mall sold - Vimarsana News

Hemingways tenants nervous as mall sold

Properties belonging to the debt-ridden Rebosis Property Fund Ltd, including East London's Hemingways Mall, have been sold for just more than R7bn.

Mr Price sets out growth strategy - Vimarsana News

Mr Price sets out growth strategy

The retailer aims to sell off excess stock and grow new acquisitions.

Why more retailers are entering the clothing market - Vimarsana News

Why more retailers are entering the clothing market

Value clothing retailers are aggressively expanding to tap into consumer demand for affordable and basic clothing as the economy stagnates.

Ackermans & van Haaren confirms result outlook for the full year 2023 - Vimarsana News

Ackermans & van Haaren confirms result outlook for the full year 2023

Dear shareholder, Dear Madam, Dear Sir, please find attached our trading update for the first quarter of 2023. Best regards Ackermans & van Haaren ... | May 17, 2023

Funds advised by Convergent Finance, Ackermans & van Haaren, and Ashish Dandekar to Co-promote Camlin Fine Sciences - Vimarsana News

Funds advised by Convergent Finance, Ackermans & van Haaren, and Ashish Dandekar to Co-promote Camlin Fine Sciences

Mumbai (Maharashtra) [India], April 17 (ANI/NewsVoir): Ashish Dandekar, funds advised by Convergent Finance LLP, and Belgium-based Ackermans & van Haaren ('Co-promoters'), have entered into a cooperation agreement to become co-promoters of Camlin Fine Sciences Limited ('CFS'), a specialty chemicals company headquartered in Mumbai, India, listed on the Bombay Stock exchange, with global operations across Asia-Pacific, Europe, and the Americas.